Thomas Simmerer takes over sales at Carl Zeiss Meditec

Succeeds Ulrich Krauss as member of the management board with responsibility for sales

Thomas Simmerer has taken over as a member of the management board responsible for sales at Carl Zeiss Meditec in Germany. He succeeds Ulrich Krauss who has transferred to the management board of Carl Zeiss Vision International, a subsidiary of the Carl Zeiss Group.

‘I am looking forward to my new responsibilities and will maintain and expand the successful sales and service structure at Carl Zeiss Meditec in the respective markets,’ said Simmerer.

Simmerer has extensive experience in medical technology. He was in charge of the Microsurgery strategic business unit in Oberkochen from October 2008. Before joining the medical wing of Carl Zeiss, the mechanical engineer led the top-performing business unit, among others, of Dräger Medical in Lübeck from 1996 to 2008. Prior to this, he was responsible for different sales areas at Heraeus in Hanau.

You may also like

Pharma 5.0

ZEISS and Concept Life Sciences partner to advance automated workflows and AI-powered image analysis in spatial biology

The collaboration focusses on high-throughput imaging, AI-driven data analysis and streamlined integration into lab systems, aiming to improve efficiency and data quality for areas such as drug discovery and cancer research
Research & Development

ZEISS launches initiative to work closely with scientists during experiments

The company is set to partner with leading research institutions such as Max Planck Florida Institute for Neuroscience, where they will be working closely with scientists
Research & Development

Medicines Discovery Catapult and ZEISS set sights on advancing microscopy in drug discovery

Medicines Discovery Catapult (MDC) and ZEISS have joined forces to improve drug discovery and early development of complex medicines by harnessing the power of advanced microscopy solutions
Manufacturing

Delivering cutting-edge technology

WITec and ZEISS have collaborated to provide a fully integrated instrument, featuring a standard, unmodified vacuum chamber and scanning electron microscope (SEM) column along with a complete confocal Raman microscope and spectrometer
Manufacturing

Replacing discontinued OEM degasser modules

Biotech Fluidics introduces direct replacement OEM degasser modules based on upgraded vacuum technology to support continued fluidic instrument supply without costly redesigns
Cell & Gene Therapy

NGI Stockholm becomes first certified service provider for Epigenica's EpiFinder platform

Epigenica has signed an agreement with the National Genomics Infrastructure in Stockholm to offer end-to-end EpiFinder workflows for histone and DNA methylation profiling, establishing the first certified service provider in what the company describes as a growing global partner network
Manufacturing

etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage

etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027
Subscribe now